Pharmaceutical - Pharmaceutical, Russia

Filter

Current filters:

PharmaceuticalRussia

Popular Filters

1 to 25 of 62 results

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

11-12-2014

R-Pharm, one of Russia’s largest pharmaceutical producers, together with Russian Venture Company (RVC)…

FinancialPharmaceuticalPharmstandardR-PharmResearchRussia

Russian Ministry of Health reveals new classification of drugs for domestic market

Russian Ministry of Health reveals new classification of drugs for domestic market

10-12-2014

The Russian Ministry of Health has designed a new classification of drugs for the domestic pharmaceutical…

FinancialHealthcarePharmaceuticalPharmacologyRussia

Russia may face a shortage of drugs against HIV

Russia may face a shortage of drugs against HIV

02-12-2014

Russia may face a shortage of drugs against HIV, due to disruptions of state auctions for the public…

Anti-viralsHealthPharmaceuticalProductionRussia

Russia faces steady growth of drug prices

Russia faces steady growth of drug prices

02-12-2014

Drug prices in Russia are steadily growing, due to the deterioration of the local business environment…

PharmaceuticalPharmaceuticals policyPharmacologyPricingRussia

Big pharma increasingly collaborating with Indian companies

Big pharma increasingly collaborating with Indian companies

26-11-2014

Even as multinational pharma majors are looking for new ways to squeeze costs along the whole value chain,…

Gilead SciencesIndiaLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalRussia

AstraZeneca plans further Russian expansion

25-11-2014

Anglo-Swedish pharma major AstraZeneca plans to continue active development on the Russian pharmaceutical…

AstraZenecaFinancialPharmaceuticalProductionRussia

Russian government predicts bright prospects to national pharma industry

Russian government predicts bright prospects to national pharma industry

25-11-2014

The Russian pharmaceutical industry is booming, despite the economic recession in the country and devaluation…

Markets & MarketingPharmaceuticalPricingRegulationRussia

Russian government to start checks for GMP compliance of domestic drug producers

Russian government to start checks for GMP compliance of domestic drug producers

18-11-2014

The Russian government plans to start massive checks of the domestic producers of drugs, as well as drug…

PharmaceuticalProductionRegulationRussiaRussian government

Ukraine plans to ban drug imports from Russia

Ukraine plans to ban drug imports from Russia

13-11-2014

The Ukrainian government is considering imposing a ban on the import of drugs from Russia. This comes…

Markets & MarketingPharmaceuticalPoliticsRussiaUkraine

Fresenius Kabi dumps planned Russian joint venture

09-11-2014

Fresenius Kabi and its partners Sistema JSFC and Zenitco Finance Management have mutually agreed to terminate…

BinnopharmFinancialFreseniusFresenius KabiMergers & AcquisitionsPharmaceuticalProductionRussia

Global Pharma may suspend production of vital drugs for Russia

07-11-2014

Global pharmaceutical producers are considering suspending of production of vital drugs for the Russian…

FinancialPharmaceuticalPricingProductionRussia

AOP Orphan brings Thromboreductin to Russian market

04-11-2014

Austria-based rare diseases specialist AOP Orphan is expanding its sales area for Thromboreductin (anagrelide)…

AnagrelideAOP OrphanMarkets & MarketingPharmaceuticalRare diseasesRussiaThromboreductin

Russian Parliament to restrict imports of unregistered drugs

30-10-2014

The Russian National Parliament (State Duma) plans to impose a ban on the imports of unregistered drugs…

PharmaceuticalPoliticsRegulationRussia

Russian approval for Norgine/Takeda’s MoviPrep

28-10-2014

Netherlands-headquartered independent drugmaker Norgine says that its partner, Japan’s largest pharma…

Gastro-intestinalsMoviPrepNorginePharmaceuticalRegulationRussiaTakeda Pharmaceutical

Russian government to introduce state regulation of drug prices in domestic market

Russian government to introduce state regulation of drug prices in domestic market

27-10-2014

The Russian government is considering introducing state regulation of prices for drugs in the country,…

PharmaceuticalPoliticsPricingRussiaRussian government

Oriola-KD considering selling Russian business

21-10-2014

Finland’s Oriola-KD, a leading pharmaceutical retail and wholesale companies operating in Northern…

Mergers & AcquisitionsOriola-KDPharmaceuticalRussia

Pfizer looks set to win $100 million Russian vaccines contract

16-10-2014

The Swiss unit of US pharma giant Pfizer has remained the only bidder for the 3.47 billion-rouble ($100…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

15-10-2014

Japanese drugmaker Kyorin Pharmaceutical and R-Pharm, one of Russia’s largest pharmaceutical producers,…

Genito-urinaryimidafenacinJapanKyorin PharmaceuticalsLicensingOno PharmaceuticalPharmaceuticalR-PharmRussiaStayblaUritos

Growth set to return to CIS by 2015 with Kazakhstan in the lead

Growth set to return to CIS by 2015 with Kazakhstan in the lead

13-10-2014

Growth is set to return to markets in the Commonwealth of Independent States between 2015 and 2019, according…

GenericsKazakhstanMarkets & MarketingPharmaceuticalRussiaUkraine

Novartis suspends commissioning of new Russian plant

13-10-2014

Swiss pharma major Novartis has decided to suspend the commissioning of its new Russian plant, which…

FinancialNovartisPharmaceuticalProductionRussia

Russia to start vaccines supplies to Central and South America

13-10-2014

Russia plans to start active supplies of vaccines to the Central and South America region during the…

Markets & MarketingPharmaceuticalProductionRussiaSouth AmericaVaccines

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

08-10-2014

US pharma giant Pfizer and UK peer GlaxoSmithKline plan to compete for the 3.47 billion-rouble ($120…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

National Immunobiological Co to invest $100 million in innovative drugs production in Russia

National Immunobiological Co to invest $100 million in innovative drugs production in Russia

08-10-2014

Russia’s National Immunobiological Company (NIC), which is part of Rostec State Corp and Genfa, one…

FinancialGenfaNational Immunobiological CompanyPharmaceuticalProductionRostecRussia

Innovative and orphan drugs to become more accessible in Russia

Innovative and orphan drugs to become more accessible in Russia

30-09-2014

The Russian Parliament (State Duma) plans to ease access to innovative and orphan drugs to the Russian…

PharmaceuticalPharmacologyRegulationResearchRussia

1 to 25 of 62 results

Back to top